Particle Characterization for USP <788>, <789> & <790>: Why It’s Critical for Pharma Compliance

Introduction

In the pharmaceutical industry, patient safety is non-negotiable—and one of the most overlooked yet critical risks is particulate contamination in injectable products. Whether visible or subvisible, particles can compromise product quality, trigger regulatory action, and even pose life-threatening risks to patients.

This is where Particle Characterization for USP <788>, <789> & <790> becomes essential. These USP chapters define strict requirements for detecting, analyzing, and controlling particulate matter in pharmaceutical products.

If you are involved in Quality Control, Manufacturing, Validation, or Regulatory Affairs, understanding particle characterization is no longer optional—it’s a compliance necessity.

In this blog, we’ll break down why Particle Characterization for USP <788>, <789> & <790> is critical, how it impacts compliance, and how you can implement it effectively in your pharma operations.

Understanding USP <788>, <789> & <790>

Before diving deeper, let’s simplify what these USP chapters mean:

USP <788> – Particulate Matter in Injections

This chapter focuses on subvisible particles in injectable drugs. It defines limits and testing methods such as:

• Light Obscuration
• Microscopic Particle Count

👉 Applies mainly to injectable and parenteral products.

USP <789> – Particulate Matter in Ophthalmic Solutions

USP <789> is specifically designed for ophthalmic solutions, where even smaller particles can cause irritation or damage.

USP <790> – Visible Particulates in Injections

This chapter addresses visible particles, which must be completely absent in injectable products.

👉 Visual inspection plays a critical role here.

Why Particle Characterization Is Critical for Compliance

1. Patient Safety Comes First

Particles like glass, fibers, or rubber fragments can enter products during manufacturing. These contaminants can:

• Cause embolism
• Trigger immune responses
• Lead to severe complications

As highlighted in industry practices, visible particulates in injectables are a direct threat to patient safety and must be strictly controlled

2. Regulatory Compliance Is Non-Negotiable

Regulatory bodies like USFDA, EMA, and WHO strictly enforce USP standards. Failure to comply can result in:

• Warning letters
• Product recalls
• Import alerts
• Plant shutdowns

👉 Particle Characterization for USP <788>, <789> & <790> ensures you meet these regulatory expectations consistently.

3. Audit Readiness & Inspection Success

During audits, inspectors often ask:

• How do you identify particulate sources?
• What is your particle size distribution data?
• How do you ensure consistency in testing?

Proper particle characterization helps you:

• Provide data-backed answers
• Demonstrate control over processes
• Avoid critical observations

4. Root Cause Analysis & CAPA Effectiveness

Particle characterization helps identify:

• Source of contamination (glass, metal, fibers)
• Process-related issues
• Equipment wear and tear

This enables:

• Effective CAPA implementation
• Long-term defect prevention

What Is Particle Characterization?

Particle characterization is the process of analyzing particles based on:

• Size (microns)
• Shape
• Composition
• Source

It goes beyond simple detection—it helps you understand the particle lifecycle.

Types of Particles in Pharma Products

Intrinsic Particles

Originating from the product itself:

• Protein aggregates
• API-related particles

Extrinsic Particles

External contamination sources:

• Glass fragments
• Metal particles
• Fibers
• Rubber pieces

Inherent Particles

From manufacturing process materials:

• Filter fibers
• Packaging material residues

Methods Used in Particle Characterization

1. Light Obscuration Method

• Measures particle size and count
• Used for subvisible particles

2. Microscopic Method

• Manual counting and identification
• Useful for irregular particles

3. Visual Inspection

• Detects visible particles
• Requires trained inspectors

4. Advanced Analytical Techniques

• FTIR (Fourier Transform Infrared Spectroscopy)
• SEM (Scanning Electron Microscopy)
• Raman Spectroscopy

👉 These methods help identify particle composition and origin.

Key Challenges in USP Compliance

1. Detection Sensitivity

Subvisible particles are extremely small and difficult to detect accurately.

2. Human Error in Visual Inspection

Manual inspection depends on:

• Operator skill
• Lighting conditions
• Fatigue levels

3. Variability in Particle Types

Particles vary in:

• Size
• Transparency
• Movement behavior

4. Lack of Standardized Training

Many companies lack structured training programs for:

• Visual inspectors
• QC analysts

Best Practices for Effective Particle Characterization

1. Use Certified Reference Materials

Using known-size particles helps in:

• Calibration
• Training
• Validation

2. Implement Risk-Based Approach

Focus on:

• High-risk products (injectables, biologics)
• Critical manufacturing stages

3. Train Your Workforce

Regular training ensures:

• Consistency
• Accuracy
• Compliance

4. Integrate Technology

Adopt:

• Automated inspection systems
• Data analytics tools

5. Partner with Experts

Working with specialized particle characterization services ensures:

• Accurate results
• Faster compliance
• Audit-ready documentation

Real-World Example

A sterile injectable manufacturer faced repeated audit observations due to particulate contamination.

Problem:

• High rejection rates
• Unknown particle sources

Solution:

• Implemented Particle Characterization for USP <788>, <789> & <790>
• Used advanced analytical techniques
• Trained inspection team

Result:

• 40% reduction in defects
• Zero audit observations
• Improved product quality

Role of Particle Characterization Services

Professional services help pharma companies:

• Identify particle sources
• Provide certified reports
• Support audit responses
• Ensure USP compliance

According to industry solutions, services include particle/fiber sizing with certification as per USP guidance and audit support documentation, making compliance easier and faster

Actionable Tips for Pharma Professionals

✔ Always validate your testing methods
✔ Maintain detailed documentation
✔ Conduct periodic requalification
✔ Monitor trends in particle data
✔ Use statistical tools for analysis

FAQ Section

Q1: What is the difference between USP <788> and USP <790>?

USP <788> focuses on subvisible particles, while USP <790> deals with visible particles.

Q2: Why is particle characterization important in injectables?

Because particles can directly impact patient safety and regulatory compliance.

Q3: What are common sources of particulate contamination?

• Glass
• Rubber
• Fibers
• Metal

Q4: How often should particle testing be performed?

It depends on:

• Batch size
• Product type
• Risk level

Q5: Can automation replace manual inspection?

Automation improves consistency, but manual inspection is still essential for certain cases.

Conclusion

In today’s highly regulated pharmaceutical environment, ignoring particulate matter is not an option. Whether you are dealing with injectables, ophthalmic solutions, or biologics, Particle Characterization for USP <788>, <789> & <790> is the backbone of product quality and regulatory compliance.

By implementing robust particle characterization strategies, leveraging advanced analytical tools, and partnering with expert service providers, you can ensure:

• Patient safety
• Audit readiness
• Regulatory success

If you’re looking to strengthen your compliance framework, explore professional particle characterization services that offer certified testing, audit support, and expert guidance tailored to USP requirements.

👉 Take the next step toward compliance excellence today.

Your trusted partner for pharma skills, systems, and solutions.